Sanofi’s Transparency Report Highlights the Continued Growth of Rebates Paid to Payers

And CMS ‘explanations’ for Medicare drug pricing suggest drugmakers and CMS didn’t see eye-to-eye in half of all ‘negotiations’

Brian Reid

Mar 4, 2026